Global Ganja Report

The country's leading medical cannabis advocacy group, Americans for Safe Access (ASA), filed an amicus ("friend of the court") brief Jan. 27 defending the privacy rights of patients across the US. The federal case US v. Michigan Department of Community Health is the response to the Justice Department seeking private patient records from the state's medical marijuana program.

Arizona voters approved Proposition 203, authorizing the possession of up to two-and-a-half ounces of medical marijuana, according to results released by the Arizona Secretary of State Nov. 13. The measure, voted on during the midterm elections earlier this month, was too close to call on election night and remained so until all votes were counted this weekend, resulting in a final tally of 50.13-49.87%.

Proposition 19 mastermind Richard Lee spoke to supporters in Oakland after the initiative lost by some 540,000 votes, 46-53%, the night of Nov. 2. "The fact that millions of Californians voted to legalize marijuana is a tremendous victory," Lee said, noting that the measure won 3.3 million votes. "We have broken the glass ceiling. Prop. 19 has changed the terms of the debate. And that was a major strategic goal."

The country's leading advocacy group Americans for Safe Access (ASA) issued voter guides Oct. 26, highlighting several important races in the upcoming elections, including ballot initiatives establishing two new statewide medical marijuana laws in Arizona and South Dakota, and an expansion of Oregon's law to include licensed cannabis dispensaries. At the local level, voters in California and Colorado will be deciding on dozens of local medical marijuana initiatives, including banning distribution and imposing new taxes on patients. The race for California attorney general, however, may represent the greatest threat to patients this November. ASA strongly opposes AG candidate Steve Cooley, Los Angeles District Attorney and a longtime adversary of the state's medical marijuana laws.

Oregon on June 16 became the latest state and the first in many years to officially reclassify cannabis from its status as a dangerous drug with no medical value. The Oregon Board of Pharmacy (BoP) voted 4-1 to move cannabis from Schedule I to Schedule II. The Oregon BoP decision comes after many months of deliberation and input from the public.

The city of Eugene, Ore., held a Cannabis Cup at a medical clinic May 22, where card holders got to test various strains of cannabis to determine which one best helped their conditions. "We had 25 different patients try 18 different strands of cannabis and give us there perspective on how it helps with their debilitating diseases and symptoms," said organizer Jim Greig.